共 303 条
[1]
Yazdanpanah Y(2004)Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials BMJ 328 249-53
[2]
Sissoko D(2000)Nelfinavir: an update on its use in HIV infection Drugs 59 581-620
[3]
Egger M(2000)Comparison of human immunodeficiency virus type 1 Pr55 Antimicrob Agents Chemother 44 1397-403
[4]
Bardsley-Elliot A(1988) and Prl60 Proc Natl Acad Sci U S A 85 4686-90
[5]
Plosker GL(1996) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors Antimicrob Agents Chemother 40 292-7
[6]
Speck RR(2001)Active human immunodeficiency virus protease is required for viral infectivity Antimicrob Agents Chemother 45 1086-93
[7]
Flexner C(1997)Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease Antimicrob Agents Chemother 41 2159-64
[8]
Tian C-J(1998)Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities N Engl J Med 338 1281-92
[9]
Kohl NE(2002)Activities of human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection AIDS 16 1331-40
[10]
Emini EA(2001)HIV-protease inhibitors AIDS 15 609-15